NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases

Area of Science:

• Cardiovascular Medicine
• Immunology
• Molecular Biology

Background:

• Inflammation is a critical factor in cardiovascular diseases, including atherosclerosis.
• It significantly increases the risk of cardiovascular events.
• The transcription factor NFκB (nuclear factor kappa B) plays a central role in the interplay between inflammation and cardiovascular damage.

Purpose of the Study:

• To review recent findings on inflammation's role in cardiac diseases.
• To highlight NFκB as a key functional link between inflammation and cardiac pathology.
• To explore therapeutic strategies targeting NFκB for heart failure.

Main Methods:

• Literature review of recent scientific findings.
• Focus on the molecular mechanisms involving NFκB.
• Analysis of therapeutic approaches targeting NFκB.

Main Results:

• NFκB is implicated in the development and progression of both inflammation and cardiac/vascular damage.
• Recent research underscores NFκB's pivotal role in the inflammation-cardiovascular disease axis.
• Targeting NFκB presents a promising avenue for treating cardiac conditions.

Conclusions:

• Inflammation is integral to cardiovascular disease pathogenesis.
• NFκB acts as a crucial molecular mediator in this process.
• Therapeutic inhibition of NFκB may offer a novel strategy for managing heart failure.